A10 Networks Inc
Change company Symbol lookup
Select an option...
ATEN A10 Networks Inc
VIRX Viracta Therapeutics Inc
YELP Yelp Inc
CCLV Karbon-X Corp
NCBDF Bandai Namco Holdings Inc
GTN Gray Television Inc
BKD Brookdale Senior Living Inc
PMT PennyMac Mortgage Investment Trust
EVTVD Envirotech Vehicles Inc
AUTL Autolus Therapeutics PLC
Go

Information Technology : Software | Small Cap Growth
Company profile

A10 Networks, Inc. is a provider of networking solutions that enable networks focused on reliability, availability, scalability, and cybersecurity. The Company's portfolio supports customers operating in the cloud, on-premises or in hybrid environments. The Company's product portfolio consists of six secure application solutions and two intelligent management and automation tools. Its secure application solutions include Thunder Application Delivery Controller (ADC), Lightning Application Delivery Controller (Lightning ADC), Thunder Carrier Grade Networking (CGN), Thunder Threat Protection System (TPS), Thunder SSL Insight (SSLi) and Thunder Convergent Firewall (CFW). Its intelligent management and automation tools include Harmony Controller and aGalaxy TPS. Its software solutions are available to be delivered in a variety of form factors, such as embedded in optimized hardware appliances, as bare metal software, containerized software, virtual appliances, and cloud-native software.

Price
Delayed
$14.28
Day's Change
-0.47 (-3.19%)
Bid
--
Ask
--
B/A Size
--
Day's High
14.80
Day's Low
14.24
Volume
(Light)

Today's volume of 171,019 shares is on pace to be much lighter than ATEN's 10-day average volume of 863,298 shares.

171,019

CLASS-ACTION-UPDATE-for-NTRA-ARQQ-and-UPST-Levi-&-Korsinsky-LLP-Reminds-Investors-of- Class-Actions-on-Behalf-of-Shareholders

2:10 pm ET May 18, 2022 (Accesswire) Print

NEW YORK, NY / ACCESSWIRE / May 18, 2022 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.

NTRA Shareholders Click Here: https://www.zlk.com/pslra-1/natera-inc-loss-submission-form?prid=27432&wire=1

ARQQ Shareholders Click Here: https://www.zlk.com/pslra-1/arqit-quantum-inc-f-k-a-centricus-acquisition-corp-loss-submission-form?prid=27432&wire=1

UPST Shareholders Click Here: https://www.zlk.com/pslra-1/upstart-inc-loss-submission-form?prid=27432&wire=1



* ADDITIONAL INFORMATION BELOW *

Levi & Korsinsky, LLP, Wednesday, May 18, 2022, Press release picture

Natera, Inc. (NASDAQ:NTRA)

This lawsuit is on behalf of a class of all persons and entities who purchased or otherwise acquired Natera common stock between February 26, 2020, and April 19, 2022, inclusive.

Lead Plaintiff Deadline : June 27, 2022

TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/natera-inc-loss-submission-form?prid=27432&wire=1



According to the filed complaint, (1) the Company's non-invasive prenatal test, Panorama, was not reliable and resulted in high rates of false positives; (2) the Company's screening test for kidney transplant failure, Prospera, did not have superior precision compared to competing tests; (3) as a result of defendants' false and misleading claims about Natera's technology, the Company was exposed to substantial legal and regulatory risks; (4) Natera relied upon deceptive sales and billing practices to drive its revenue growth; and (5) as a result of the foregoing, defendants' statements about the company's business, operations, and prospects lacked a reasonable basis.

Arqit Quantum Inc. f/k/a Centricus Acquisition Corp. (NASDAQ:ARQQ)

This lawsuit is on behalf of: (i) all persons or entities who purchased or otherwise acquired Arqit securities between September 7, 2021 and April 18, 2022, inclusive; and/or (ii) all holders of Centricus securities as of the record date for the special meeting of shareholders held on August 31, 2021 to consider approval of the merger between Arqit and Centricus (the "Merger") and entitled to vote on the Merger.

Lead Plaintiff Deadline : July 5, 2022

TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/arqit-quantum-inc-f-k-a-centricus-acquisition-corp-loss-submission-form?prid=27432&wire=1



According to the filed complaint, (1) Arqit's proposed encryption technology would require widespread adoption of new protocols and standards for telecommunications; (2) British cybersecurity officials questioned the viability of Arqit's proposed encryption technology in a meeting in 2020; (3) the British government was not an Arqit customer but, rather, providing grants to Arqit; (4) Arqit had little more than an early-stage prototype of its encryption system at the time of the Merger; and (5) as a result, Defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Upstart, Inc. (NASDAQ:UPST)

UPST Lawsuit on behalf of: investors who purchased November 9, 2021 - May 9, 2022

Lead Plaintiff Deadline : July 12, 2022

TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/upstart-inc-loss-submission-form?prid=27432&wire=1



According to the filed complaint, during the class period, Upstart, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) Upstart's AI model could not adequately account for macroeconomic factors such as interest rates that impact the market-clearing price for loans; (2) as a result, Upstart was experiencing a negative impact on its conversion rate; (3) as a result, the Company was reasonably likely to use its balance sheet to fund loans; and (4) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

Eduard Korsinsky, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com

SOURCE: Levi & Korsinsky, LLP





View source version on accesswire.com:

https://www.accesswire.com/701922/CLASS-ACTION-UPDATE-for-NTRA-ARQQ-and-UPST-Levi-Korsinsky-LLP-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders



comtex tracking

COMTEX_407409229/2457/2022-05-18T14:10:07

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.